Abbott's Solvay Deal: Don't Get Too Excited
Sept. 28 (Bloomberg) -- Johnson & Johnson bought an 18 percent stake in Crucell NV for 301.8 million euros ($442 million), to form a partnership on flu shots and therapies, eight months after Wyeth abandoned a deal with the Dutch ...